London
· Delayed Price · Currency is GBP · Price in EUR aap Implantate AG Statistics
Total Valuation
aap Implantate AG has a market cap or net worth of GBP 22.18 million. The enterprise value is 24.34 million.
| Market Cap | 22.18M |
| Enterprise Value | 24.34M |
Important Dates
The next estimated earnings date is Monday, April 14, 2025.
| Earnings Date | Apr 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +10.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 7.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 1.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.26 |
| EV / Sales | 2.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.30 |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.48 |
| Quick Ratio | 0.88 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.16 |
| Interest Coverage | -12.95 |
Financial Efficiency
Return on equity (ROE) is -17.22% and return on invested capital (ROIC) is -14.78%.
| Return on Equity (ROE) | -17.22% |
| Return on Assets (ROA) | -11.28% |
| Return on Capital (ROIC) | -14.78% |
| Revenue Per Employee | 92,563 |
| Profits Per Employee | -17,886 |
| Employee Count | 111 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 0.18 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 57.79 |
| Average Volume (20 Days) | 109 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, aap Implantate AG had revenue of GBP 10.27 million and -1.99 million in losses. Loss per share was -0.27.
| Revenue | 10.27M |
| Gross Profit | 9.01M |
| Operating Income | -3.32M |
| Pretax Income | -2.89M |
| Net Income | -1.99M |
| EBITDA | -2.62M |
| EBIT | -3.32M |
| Loss Per Share | -0.27 |
Balance Sheet
The company has 1.20 million in cash and 2.30 million in debt, giving a net cash position of -1.09 million.
| Cash & Cash Equivalents | 1.20M |
| Total Debt | 2.30M |
| Net Cash | -1.09M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 12.20M |
| Book Value Per Share | 1.36 |
| Working Capital | 6.47M |
Cash Flow
In the last 12 months, operating cash flow was -1.82 million and capital expenditures -161,506, giving a free cash flow of -1.98 million.
| Operating Cash Flow | -1.82M |
| Capital Expenditures | -161,506 |
| Free Cash Flow | -1.98M |
| FCF Per Share | n/a |
Margins
Gross margin is 87.72%, with operating and profit margins of -32.27% and -19.32%.
| Gross Margin | 87.72% |
| Operating Margin | -32.27% |
| Pretax Margin | -28.12% |
| Profit Margin | -19.32% |
| EBITDA Margin | -25.48% |
| EBIT Margin | -32.27% |
| FCF Margin | n/a |
Dividends & Yields
aap Implantate AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.03% |
| Shareholder Yield | -20.03% |
| Earnings Yield | -8.95% |
| FCF Yield | -8.92% |
Stock Splits
The last stock split was on October 29, 2020. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 29, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
aap Implantate AG has an Altman Z-Score of -0.15. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.15 |
| Piotroski F-Score | n/a |